{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:25:06Z","timestamp":1790144706998,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013321","name":"Shenzhen Institutes of Advanced Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omta.2026.201725","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:23:44Z","timestamp":1774715024000},"page":"201725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineering novel AAV capsids by broadly attenuated and subsequent muscle-specific tropism in mice and NHPs"],"prefix":"10.1016","volume":"34","author":[{"given":"Yue","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5835-8134","authenticated-orcid":false,"given":"Huapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201725_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.08.017","article-title":"Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates","volume":"13","author":"Gao","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omta.2026.201725_bib3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib4","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omta.2026.201725_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/mt.2012.258","article-title":"Minimizing the inhibitory effect of neutralizing antibody for efficient gene expression in the liver with adeno-associated virus 8 vectors","volume":"21","author":"Mimuro","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.18609\/cgti.2019.058","article-title":"Challenges and opportunities of machine-guided capsid engineering for gene therapy","volume":"5","author":"Kelsic","year":"2019","journal-title":"Cell Gene Ther. Insights"},{"key":"10.1016\/j.omta.2026.201725_bib7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ymthe.2020.07.009","article-title":"Broader Implications of Progressive Liver Dysfunction and Lethal Sepsis in Two Boys following Systemic High-Dose AAV","volume":"28","author":"Morales","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41587-020-0642-9","article-title":"High-dose AAV gene therapy deaths","volume":"38","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201725_bib9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","article-title":"Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne\u2019s Muscular Dystrophy","volume":"389","author":"Lek","year":"2023","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omta.2026.201725_bib11","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ymthe.2024.12.027","article-title":"AAV-RNAi constructs promote DRG toxicity","volume":"33","author":"Jun","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201725_bib14","doi-asserted-by":"crossref","first-page":"101105","DOI":"10.1016\/j.omtm.2023.09.001","article-title":"Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain","volume":"31","author":"Daniel Stone","year":"2023","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.08.021","article-title":"High-titer AAV disrupts cerebrovascular integrity and induces lymphocyte infiltration in adult mouse brain","volume":"31","author":"Guo","year":"2023","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib16","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coph.2015.08.002","article-title":"Engineering the AAV capsid to optimize vector\u2013host-interactions","volume":"24","author":"B\u00fcning","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.omta.2026.201725_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omta.2026.201725_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtm.2020.10.010","article-title":"Directed evolution of AAV serotype 5 for increased hepatocyte transduction and retained low humoral seroreactivity","volume":"20","author":"Qian","year":"2021","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","article-title":"Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer","volume":"37","author":"Arjomandnejad","year":"2023","journal-title":"BioDrugs"},{"key":"10.1016\/j.omta.2026.201725_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-61779-370-7_3","article-title":"AAV capsid structure and cell interactions","volume":"807","author":"Agbandje-McKenna","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omta.2026.201725_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.omtm.2020.12.006","article-title":"Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning","volume":"20","author":"Nonnenmacher","year":"2021","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib23","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41592-021-01322-0","article-title":"DELIVERing transgenes into muscle","volume":"18","author":"Vogt","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201725_bib24","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.neuron.2022.05.003","article-title":"Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems","volume":"110","author":"Chen","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.omta.2026.201725_bib25","first-page":"31","article-title":"Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS","volume":"4","author":"Stanton","year":"2023","journal-title":"M\u00e9d. Sur"},{"key":"10.1016\/j.omta.2026.201725_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymthe.2017.09.006","article-title":"In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ","volume":"26","author":"Ojala","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib27","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ymthe.2019.07.017","article-title":"AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice","volume":"27","author":"Liguore","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib28","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-022-33745-4","article-title":"Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing","volume":"13","author":"Gonzalez","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201725_bib29","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/sj.mt.6300293","article-title":"Characterization of the Relationship of AAV Capsid Domain Swapping to Liver Transduction Efficiency","volume":"15","author":"Shen","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib30","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/ncomms4075","article-title":"Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing","volume":"5","author":"Adachi","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201725_bib31","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1128\/JVI.77.12.6995-7006.2003","article-title":"Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding","volume":"77","author":"Opie","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201725_bib32","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.tibtech.2022.11.006","article-title":"Evading and overcoming AAV neutralization in gene therapy","volume":"41","author":"Earley","year":"2023","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.omta.2026.201725_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2023.01.010","article-title":"Binding and neutralizing anti-AAV antibodies Detection and implications for rAAV-mediated gene therapy","volume":"31","author":"Schulz","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib34","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Cell Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery","volume":"16","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201725_bib35","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/hum.2020.196","article-title":"Adeno-Associated Virus Capsid-Promoter Interactions in the Brain Translate from Rat to the Nonhuman Primate","volume":"31","author":"Bohlen","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201725_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/humc.2017.070","article-title":"Use of adeno-associated virus vector for cardiac gene delivery in large-animal surgical models of heart failure","volume":"28","author":"Katz","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL\/6J Mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225206","article-title":"Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids","volume":"14","author":"Huang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201725_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41434-024-00466-w","article-title":"Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles","volume":"31","author":"Bunuales","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201725_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/hum.2019.186","article-title":"Ly6a Differential Expression in Blood\u2013Brain Barrier Is Responsible for Strain Specific Central Nervous System Transduction Profile of AAV-PHP.B","volume":"31","author":"Batista","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201725_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coviro.2016.08.001","article-title":"Cellular transduction mechanisms of adeno-associated viral vectors","volume":"21","author":"Berry","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omta.2026.201725_bib42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cell.2019.12.030","article-title":"Cryo-EM Reveals Integrin-Mediated TGF-\u03b2 Activation without Release from Latent TGF-\u03b2","volume":"180","author":"Campbell","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201725_bib43","author":"Inc."},{"key":"10.1016\/j.omta.2026.201725_bib44","series-title":"A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy","year":"2017"},{"key":"10.1016\/j.omta.2026.201725_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110939","article-title":"Satellite cell-specific deletion of Cipc alleviates myopathy in mdx mice","volume":"39","author":"Zheng","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.omta.2026.201725_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/hum.2016.171","article-title":"Future of rAAV gene therapy: platform for RNAi, gene editing, and beyond","volume":"28","author":"Valdmanis","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201725_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14712598.2021.1865303","article-title":"Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy","volume":"21","author":"Rodr\u00edguez-M\u00e1rquez","year":"2021","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib48","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ymthe.2021.07.010","article-title":"A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system","volume":"29","author":"Kondratov","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib49","doi-asserted-by":"crossref","first-page":"27053","DOI":"10.1073\/pnas.1910061116","article-title":"A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism","volume":"116","author":"Davidsson","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201725_bib50","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1073\/pnas.0813207106","article-title":"A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection","volume":"106","author":"Yang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201725_bib51","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.2025","article-title":"Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy","volume":"15","author":"Chen","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201725_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","article-title":"Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle","volume":"28","author":"Asokan","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201725_bib53","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/JVI.00076-06","article-title":"Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism","volume":"80","author":"Perabo","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201725_bib54","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.ymthe.2021.10.020","article-title":"Scratching the surface of RGD-directed AAV capsid engineering","volume":"29","author":"Zolotukhin","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib55","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a Heparin-Binding Motif on Adeno-Associated Virus Type 2 Capsids","volume":"77","author":"Kern","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201725_bib56","article-title":"Ancestral library identifies conserved reprogrammable liver motif on AAV capsid","volume":"3","author":"Zinn","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omta.2026.201725_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.omtm.2022.12.014","article-title":"Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution","volume":"28","author":"Cabanes-Creus","year":"2023","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omtm.2018.03.004","article-title":"A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates","volume":"9","author":"Wang","year":"2018","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013533","article-title":"A single amino acid variant in the variable region I of AAV capsid confers liver detargeting","volume":"21","author":"Xing","year":"2025","journal-title":"PloS Pathogens"},{"key":"10.1016\/j.omta.2026.201725_bib60","article-title":"Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heart","volume":"33","author":"Elad Firnberg","year":"2025","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib61","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-term follow-up of the first in human intravascular delivery of AAV for gene transfer: AAV2-hFIX16 for severe hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201725_bib62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omtm.2018.03.004","article-title":"A rationally engineered capsid variant of AAV9 for systemic CNS-directed and peripheral tissue-detargeted gene delivery in neonates","volume":"9","author":"Wang","year":"2018","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201725_bib63","first-page":"38","article-title":"Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders","volume":"23","author":"El Andari","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omta.2026.201725_bib64","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1038\/s41467-024-52002-4","article-title":"An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species","volume":"15","author":"Vu Hong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201725_bib65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.omtm.2018.09.003","article-title":"Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer","volume":"11","author":"Wang","year":"2018","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:32:04Z","timestamp":1788553924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3117387X26000601"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201725","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering novel AAV capsids by broadly attenuated and subsequent muscle-specific tropism in mice and NHPs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201725"}}